نویسندگان
Mostafa Hosseini, Adnan Tizmaghz, Hamidreza Alizadeh Otaghvar, Marjan Shams
تاریخ انتشار
2014
توضیح
Introduction: Fibrocystic changes are considered as common and benign changes in the breast tissue. This study aimed to determine the prevalence of pathologic changes Including fibrocystic changes, hyperplasia, and carcinoma in breast tissue specimens of patients underwent reduction Mammoplasty. Methods: 128 consecutive patients over a period of 5 years from 2007 to 2012, who were admitted at the Rasool-Akram, Firoozgar, and Sadr Hospitals for reduction mammoplasty, were investigated in this study. In all patients an average of 500 grams of breast tissue from each side during mammoplasty was sent for pathologic evaluation. The variables measured in the study included age, fibrocystic changes, and hyperplastic changes in the pathology specimens of these patients. Data analysis was performed using SPSS 18 software. Results: 71 patients (55.5%) had fibrocystic changes. 6 patients (4.7%) were reported to have hyperplasia. Carcinoma was not observed in any of the samples. The prevalence of fibrocystic changes increased with age. Hyperplastic changes were not associated with age and with fibrocystic changes. But it was the most common in the ages between 31 and 40 years. Conclusion: Fibrocystic breast changes are common, and their prevalence increases with age. However, they are not associated with hyperplasia and cancer risk.